Soleno Therapeutics, Inc.
SLNO
$76.70
-$0.08-0.10%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -280.98% | -351.04% | -295.33% | -129.92% | -94.88% |
| Total Depreciation and Amortization | 2.20% | 1.48% | 0.82% | 0.20% | -0.20% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 648.84% | 977.81% | 984.38% | 471.51% | 345.30% |
| Change in Net Operating Assets | -147.91% | 105.53% | 590.13% | -113.23% | 1,404.11% |
| Cash from Operations | -190.57% | -177.05% | -116.33% | -93.84% | -45.36% |
| Capital Expenditure | -1,827.27% | -- | -3,400.00% | -216.67% | 15.38% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 24.25% | -- | -- | -- | -- |
| Cash from Investing | 24.07% | -- | -3,868,650.00% | -3,935,983.33% | -886,392.31% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -8.55% | -9.38% | 395.07% | 1,719.60% | 52,811.40% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 18.98% | 18.33% | 395.07% | 1,719.60% | 301,495.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 10.04% | -152.72% | -112.31% | 901.70% | 265.75% |